Gene · 7481
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| iPSC-derived mesenchymal cells that support alveolar organoid development. | Cell Rep Methods | 2022 | 36313800 | PubTator, text mining | PubMed |
| Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer. | Int J Mol Sci | 2022 | 36293321 | PubTator, text mining | PubMed |
| Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions. | Cells | 2022 | 36291115 | PubTator, text mining | PubMed |
| Integrated analysis of miRNAs and mRNA profiling reveals the potential roles of miRNAs in sheep hair follicle development. | BMC Genomics | 2022 | 36273119 | PubTator, text mining | PubMed |
| Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis. | Ann Transl Med | 2022 | 36267705 | PubTator, text mining | PubMed |
| Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution. | Commun Biol | 2022 | 36224302 | PubTator, text mining | PubMed |
| Cancer-associated Fibroblasts Communicate with Breast Tumor Cells Through Extracellular Vesicles in Tumor Development. | Technol Cancer Res Treat | 2022 | 36222020 | PubTator, text mining | PubMed |
| High Expression of ATP6V1C2 Predicts Unfavorable Overall Survival in Patients With Colon Adenocarcinoma. | Front Genet | 2022 | 36212133 | PubTator, text mining | PubMed |
| A multi-omics longitudinal study of the murine retinal response to chronic low-dose irradiation and simulated microgravity. | Sci Rep | 2022 | 36207342 | PubTator, text mining | PubMed |
| Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function. | FASEB J | 2022 | 36196997 | PubTator, text mining | PubMed |
| Investigating a Genetic Link Between Alzheimer's Disease and CADASIL-Related Cerebral Small Vessel Disease. | Mol Neurobiol | 2022 | 36175824 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies. | Front Physiol | 2022 | 36117702 | PubTator, text mining | PubMed |
| WNT5A-RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer. | Cancer Res | 2022 | 36102736 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis. | Biology (Basel) | 2022 | 36101353 | PubTator, text mining | PubMed |
| Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy. | Front Immunol | 2022 | 36072583 | PubTator, text mining | PubMed |
| Changes in chromatin accessibility are not concordant with transcriptional changes for single-factor perturbations. | Mol Syst Biol | 2022 | 36069349 | PubTator, text mining | PubMed |
| Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. | Cancer Discov | 2022 | 36027053 | PubTator, text mining | PubMed |
| Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. | Vaccines (Basel) | 2022 | 36016136 | PubTator, text mining | PubMed |
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development. | Front Immunol | 2022 | 36003399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7481/papers?page=14